KDI tripeptide from laminin: a novel approach to treat neurodegenerative disorders.
The excessive release of glutamate following brain injury is responsible for the phenomenon of glutamate excitotoxicity, mediated through glutamate receptors, resulting in apoptotic cell death. KDI ameliorates excitotoxicity and regenerates damaged nerve cells.
Humans↗